Cellebrite DI Ltd. (CLBTW)
Cellebrite DI Statistics
Share Statistics
Cellebrite DI has 201.55M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 201.55M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is null and the forward PE ratio is null.
| PE Ratio | null |
| Forward PE | n/a |
| PS Ratio | 5.07 |
| Forward PS | null |
| PB Ratio | 48.13 |
| P/FCF Ratio | null |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cellebrite DI.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of null.
| Current Ratio | 1.64 |
| Quick Ratio | 1.6 |
| Debt / Equity | null |
| Debt / EBITDA | 0.33 |
| Debt / FCF | 0.15 |
| Interest Coverage | null |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $322.53K |
| Profits Per Employee | $-80.46K |
| Employee Count | 1,008 |
| Asset Turnover | 0.6 |
| Inventory Turnover | 5.05 |
Taxes
| Income Tax | 5.54M |
| Effective Tax Rate | -7.33% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 1.52, so Cellebrite DI's price volatility has been higher than the market average.
| Beta | 1.52 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 4.3 |
| 200-Day Moving Average | 2.57 |
| Relative Strength Index (RSI) | 51.08 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Cellebrite DI had revenue of 325.11M and earned -81.1M in profits. Earnings per share was -0.43.
| Revenue | 325.11M |
| Gross Profit | 271.88M |
| Operating Income | 33.28M |
| Net Income | -81.1M |
| EBITDA | 43.29M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.43 |
Balance Sheet
The company has 189.52M in cash and 14.13M in debt, giving a net cash position of 175.39M.
| Cash & Cash Equivalents | 189.52M |
| Total Debt | 14.13M |
| Net Cash | 175.39M |
| Retained Earnings | 118.14M |
| Total Assets | 556.58M |
| Working Capital | 172.01M |
Cash Flow
In the last 12 months, operating cash flow was 102.06M and capital expenditures -7.92M, giving a free cash flow of 94.14M.
| Operating Cash Flow | 102.06M |
| Capital Expenditures | -7.92M |
| Free Cash Flow | 94.14M |
| FCF Per Share | 0.5 |
Margins
Gross margin is 83.63%, with operating and profit margins of 10.24% and -24.95%.
| Gross Margin | 83.63% |
| Operating Margin | 10.24% |
| Pretax Margin | -23.24% |
| Profit Margin | -24.95% |
| EBITDA Margin | n/a |
| EBIT Margin | 10.24% |
| FCF Margin | 28.96% |
Dividends & Yields
CLBTW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for CLBTW.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 4.66 |
| Piotroski F-Score | 5 |